Plasma and tissue disposition of florfenicol in Escherichia coli lipopolysaccharide-induced endotoxaemic sheep

References

• Anadón A, Martínez MA, Martínez M, et al. (2008). Plasma and tissue depletion of florfenicol and florfenicol-amine in chickens. J Agric Food Chem 56:11049–56
   PubMed Web of Science ®Google Scholar
• AVMA. (2013). Guidelines for euthanasia in animals. 2013 edition. Schaumburg (IL): American Veterinary Medical Association
   Google Scholar
• Baggot ID. (2001). Interpretation of changes in drug disposition and interspecies scaling. In: The physiological basis of veterinary clinical pharmacology. Oxford: Wiley-Blackwell, 92–135
   Google Scholar
• Berge ACB, Sischo WM, Craigmill AL. (2006). Antimicrobial susceptibility patterns of respiratory tract pathogens from sheep and goats. JAMA 229:1279–81
   Web of Science ®Google Scholar
• Cannon M, Harford S, Davies J. (1990). A comparative study on the inhibitory actions of chloramphenicol, thiamphenicol and some fluorinated derivatives. Antimicrob Agents Chemother 26:306–17
   Google Scholar
• Chvojka J, Sykora R, Karvunidis T, et al. (2010). New developments in septic acute kidney injury. Physiol Res 59:859–69
   PubMed Web of Science ®Google Scholar
• De Craene BA, Deprez P, D'Haese E, et al. (1997). Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves. Antimicrob Agents Chemother 41:1991–5
   PubMed Web of Science ®Google Scholar
• Ebersole JL, Cappelli D. (2000). Acute-phase reactants in infections and inflammatory diseases. Periodontology 40:19–49
   Web of Science ®Google Scholar
• Elmas M, Yazar E, Kamil U, et al. (2008). Pharmacokinetics of enrofloxacin and flunixin meglumine and interactions between both drugs after intravenous co-administration in healthy and endotoxaemic rabbits. Vet J 177:418–24
   PubMed Web of Science ®Google Scholar
• Elmas M, Yazar E, Uney K, Er A. (2006). Influence of Escherichia coli endotoxin-induced on the pharmacokinetics of enrofloxacin after intravenous administration in rabbits. J Med Vet A 53:410–14
   Web of Science ®Google Scholar
• EMEA. (1998). Committee for Veterinary Medicinal Products/European Agency for the Evaluation of Medicinal Products. Guidelines on validation of analytical procedures: Methodology (VICH GL.2). London, UK: EMEA, 1–10
   Google Scholar
• EMEA. (1999). Committee for Veterinary Medicinal Products/European Agency for the Evaluation of Medicinal Products: Florfenicol (Extension to pigs). Summary Report (4). EMEA/MRL/591/99-FINAL
   Google Scholar
• Eng J. (2003). Sample size estimation: how many individuals should be studied? Radiology 227:309–13
   PubMed Web of Science ®Google Scholar
• Goralski KB, Hartmann G, Piquette-Miller M, Renton KW. (2003). Down regulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 139:35–48
   PubMed Web of Science ®Google Scholar
• Huh Y, Keep RF, Smith DE. (2013). Impact of lipopolysaccharide-induced inflammation on the disposition of aminocephalosporin cefadroxil. Antimicrob Agents Chemother 57:6171–8
   PubMed Web of Science ®Google Scholar
• Jianzhong S, Xiubo L, Haiyang J, Walter HH. (2004). Bioavailability and pharmacokinetics of florfenicol in healthy sheep. J Vet Pharmacol Ther 27:163–8
   PubMed Web of Science ®Google Scholar
• Jin L, Li L, Nation RL, Nicolazzo JA. (2011). Impact of P-glycoprotein and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice. Antimicrob Agents Chemother 55:502–7
   PubMed Web of Science ®Google Scholar
• Kang YH, Falk MC, Bentley TB, Lee C-H. (1995). Distribution and role of the lipopolysaccharide in the pathogenesis of acute renal proximal tubule injury. Shock 4:441–9
   PubMed Web of Science ®Google Scholar
• Lane VM, Villarroel A, Wetzlich S, et al. (2007). Tissue residues of florfenicol in sheep. J Vet Pharmacol Ther 31:178–80
   Web of Science ®Google Scholar
• Li J, Ding S, Zhang S, et al. (2006). Residue depletion of florfenicol and its metabolite florfenicol amine in swine tissues after intramuscular administration. J Agric Food Chem 54:9614–19
   PubMed Web of Science ®Google Scholar
• Monshouwer M, Witkamp RF. (2000). Cytochromes and cytokines: changes in drug disposition in animals during an acute phase response: a mini-review. Vet Q 22:17–20
   PubMed Web of Science ®Google Scholar
• Morgan ET. (2009). Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther 85:434–8
   PubMed Web of Science ®Google Scholar
• Palma C, Ramírez J, Benavente A, et al. (2012). Pharmacokinetics of florfenicol and florfenicol-amine after intravenous administration in sheep. J Vet Pharmacol Ther 35:596–605
   PubMed Web of Science ®Google Scholar
• Park BK, Lim JH, Kim MS, et al. (2007). Pharmacokinetics of florfenicol and its major metabolite, florfenicol-amine, in rabbits. J Vet Pharmacol Ther 30:32–6
   PubMed Web of Science ®Google Scholar
• Pérez R, Palma C, Drápela C, et al. (2015). Pharmacokinetics of florfenicol after intravenous administration in Escherichia coli lipopolysaccharide-induced endotoxemic sheep. J Vet Pharmacol Ther 38:144–9
   PubMed Web of Science ®Google Scholar
• Post LO, Cope CV, Farrel DE, et al. (2002). Influence of porcine Actinobacillus pleuropneumoniae on the pharmacokinetic parameters of enrofloxacin. J Pharmacol Exp Ther 301:217–22
   PubMed Web of Science ®Google Scholar
• Post LO, Farrel DE, Cope CV, et al. (2003). The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine. J Pharmacol Exp Ther 304:889–95
   PubMed Web of Science ®Google Scholar
• Rao GS, Ramesh SR, Ahmad HA, et al. (2000). Effects of endotoxin-induced fever and probenecid on disposition of enrofloxacin and its metabolite ciprofloxacin after intravascular administration of enrofloxacin in goats. J Vet Pharmacol Ther 23:365–72
   PubMed Web of Science ®Google Scholar
• Renton KW. (2007). Cytokines and pharmacokinetic drug interactions. In: House RV, Descotes J, eds. Cytokines in human health. Inmunotoxicology, phatology and therapeutic applications. Totowa, NJ: Humana Press, 275–96
   Google Scholar
• Riviere J. (1999). Comparative pharmacokinetics: principles, techniques and applications. Ames, IA: Iowa State University Press, 148–67
   Google Scholar
• Saitoh T, Kokue E, Shimoda M. (1999). The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits. J Vet Pharmacol Ther 22:87–95
   PubMed Web of Science ®Google Scholar
• Sams R. (1994). Florfenicol: Chemistry and metabolism of a novel spectrum antibiotic. In Proceedings of the XVIII World Buiatrics Congress, Bologna, Italy, pp. 13–17
   Google Scholar
• Shyu C-L, Lin C-C, Hsuan S-L, et al. (2010). Suppurative meningitis in a 7 day-old Formosan sambar deer (Cervus unicolor swinhoei) caused by Escherichia coli. Can Vet J 51:308–10
   PubMed Web of Science ®Google Scholar
• Singbartl K, Ley K. (2004). Leukocyte recruitment and acute renal failure. J Mol Med 82:91–101
   PubMed Web of Science ®Google Scholar
• Syriopoulou VP, Harding AL, Glodmann DA, Smith AL. (1981). In vitro antibacterial activity of fluorinated analogues of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother 19:294–7
   PubMed Web of Science ®Google Scholar
• Van Miert ASJPAM. (1990). Influence of febrile disease on the pharmacokinetics of veterinary drugs. Ann Rech Vet 21:11–22
   PubMedGoogle Scholar
• Varma KJ, Adams PE, Powers TE, et al. (1986). Pharmacokinetics of florfenicol in veal calves. J Vet Pharmacol Ther 9:412–25
   PubMed Web of Science ®Google Scholar
• Villarino N, Lesman S, Fielder A, et al. (2013). Pulmonary pharmacokinetics of tulathromycin in swine. Part I: lung homogenate in healthy pigs and pigs challenged intratracheally with lipopolysaccharide of Escherichia coli. J Vet Pharmacol Ther 36:336–9
   Web of Science ®Google Scholar